The second was that ACE2 overexpression attenuated myocardial fibrosis, improved left ventricular remodeling and cardiac function, and improved pathological symptoms and decreased mortality of rats by Kaplan-Meier survival curves in doxorubicin-induced cardiomyopathy. The gene discussed is ACE2; the disease is Myocardial fibrosis.